Long-acting semaglutide injection for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new long-acting form of semaglutide (a diabetes medication you may already take weekly) given as a depot injection. Researchers want to see if this new form is safe and works better for managing type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and have been on semaglutide 1 mg weekly for at least 3 months
- You are 18–64 years old with a BMI (weight-to-height ratio) between 25–35
- Your blood sugar control is good (HbA1c under 8%) and your kidney function is normal or mildly reduced
- You are not pregnant, not breastfeeding, and (if you can become pregnant) willing to use reliable contraception
- You have not been in another drug study within the past 3 months and do not have a history of heart or stroke
- You do not take insulin, certain older diabetes pills (sulfonylureas or glinides), or have severe liver, kidney, or thyroid disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a weekly semaglutide injection (a GLP-1 drug) to a closed-loop insulin system can help reduce the need for carb counting in people with type 1 diabetes. It aims to improve blood sugar control and make diabetes management easier.
This study tests how well a diabetes medication called semaglutide works when prescribed in everyday clinical practice in Argentina. Semaglutide comes in two forms—a pill or an injection—and the study tracks how much it lowers blood sugar over one year.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This trial tests whether semaglutide (a medicine that helps control blood sugar and weight) can improve outcomes for people with type 1 diabetes who have a higher body weight. It may help if you have had type 1 diabetes for at least 3 years and have a BMI of 30 or more, or 27 or more with a related health problem.
This study tests a small implant placed under the skin that slowly releases semaglutide, a medication that helps with weight management. It's for people who are overweight but do not have diabetes.
This study looks at how semaglutide (a medication for type 2 diabetes or weight management) affects your heart, kidneys, and overall metabolic health over time. It uses medical records from LMC endocrinology clinics to track real-world outcomes.
Hear when a new Diabete Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.